APTIMMUNE

Aptimmune is a biotechnology company that focuses on developing a muscoal vaccine against viral diseases swine. It focuses on swine vaccines and the prevention of two major diseases, Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza. It utilizes novel technologies to create effective nasal delivery vaccines against PRRSV such as the proprietary pig alveolar macrophage cell line ZMAC. The company was founded in 2010 and headquartered in St. Louis, Missouri.

#People #Financial #Website #More

APTIMMUNE

Social Links:

Linkedin

Twitter

Industry:

Biopharma Biotechnology Health Care Health Diagnostics Test And Measurement

Founded:

2010-01-01

Address:

St Louis, Missouri, United States

Country:

United States

Website Url:

http://www.aptimmune.com

Total Employee:

1+

Status:

Active

Contact:

2173334050

Email Addresses:

[email protected]

Total Funding:

8.85 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Wordpress Plugins Nginx Sitelinks Search Box

Current Advisors List

robert-bob-easter_image

Robert (Bob) Easter Board of Directors @ Aptimmune
Board_member

paul-olivo_image

Paul Olivo Board Director @ Aptimmune
Board_member

Current Employees Featured

federico-zuckermann_image

Federico Zuckermann
Federico Zuckermann Founder & Chief Scientific Officer @ Aptimmune
Founder & Chief Scientific Officer
2010-04-01

heather-bessoff_image

Heather Bessoff
Heather Bessoff CEO @ Aptimmune
CEO

steven-berger_image

Steven Berger
Steven Berger Development Director @ Aptimmune
Development Director

gary-durack_image

Gary Durack
Gary Durack Director of Operations @ Aptimmune
Director of Operations

Founder

federico-zuckermann_image

Federico Zuckermann

heather-bessoff_image

Heather Bessoff

Investors List

kemin-industries-2_image

Kemin Industries

Kemin Industries investment in Corporate Round - Aptimmune

missouri-technology-corporation_image

Missouri Technology Corporation

Missouri Technology Corporation investment in Series B - Aptimmune

st-louis-arch-angels_image

St. Louis Arch Angels

St. Louis Arch Angels investment in Series B - Aptimmune

cultivation-capital_image

Cultivation Capital

Cultivation Capital investment in Series B - Aptimmune

arsenal-capital-management_image

Arsenal Capital Management

Arsenal Capital Management investment in Series B - Aptimmune

the-yield-lab_image

The Yield Lab

The Yield Lab investment in Series B - Aptimmune

the-yield-lab_image

The Yield Lab

The Yield Lab investment in Convertible Note - Aptimmune

fox-ventures_image

Fox Ventures

Fox Ventures investment in Series A - Aptimmune

illinois-ventures_image

Illinois Ventures

Illinois Ventures investment in Series A - Aptimmune

arsenal-capital-partners_image

Arsenal Capital Partners

Arsenal Capital Partners investment in Series A - Aptimmune

Official Site Inspections

http://www.aptimmune.com

Host Informations
Whois Informations

Loading ...

More informations about "Aptimmune" on Search Engine